268 related articles for article (PubMed ID: 33893026)
21. Factors associated with perceived decline in the quality of drugs during the COVID-19 pandemic: Evidence from community-recruited cohorts of people who use drugs in Vancouver, Canada.
McAdam E; Hayashi K; Dong H; Cui Z; Sedgemore KO; Dietze P; Phillips P; Wilson D; Milloy MJ; DeBeck K
Drug Alcohol Depend; 2022 Jul; 236():109471. PubMed ID: 35489180
[TBL] [Abstract][Full Text] [Related]
22. The Pattern of Substance Use among People Who Use Drugs (PWUD) Receiving Treatment at University Malaya Medical Centre (UMMC) during the COVID-19 Pandemic and the Associated Factors.
Yahaya AZB; Yee A; Sulaiman AH
Healthcare (Basel); 2022 Jul; 10(8):. PubMed ID: 35893189
[TBL] [Abstract][Full Text] [Related]
23. Mal/adaptations: A qualitative evidence synthesis of opioid agonist therapy during major disruptions.
Salamanca-Buentello F; Cheng DK; Sabioni P; Majid U; Upshur R; Sud A
Int J Drug Policy; 2022 Mar; 101():103556. PubMed ID: 34902805
[TBL] [Abstract][Full Text] [Related]
24. The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months.
Bennett AS; Townsend T; Elliott L
Int J Drug Policy; 2022 Mar; 101():103554. PubMed ID: 34911010
[TBL] [Abstract][Full Text] [Related]
25. Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois.
Rains A; York M; Bolinski R; Ezell J; Ouellet LJ; Jenkins WD; Pho MT
Harm Reduct J; 2022 Nov; 19(1):128. PubMed ID: 36403075
[TBL] [Abstract][Full Text] [Related]
26. The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19.
McCrae K; Glegg S; Goyer MÉ; Le Foll B; Brar R; Sutherland C; Fairbairn N
Harm Reduct J; 2022 Jul; 19(1):77. PubMed ID: 35836189
[TBL] [Abstract][Full Text] [Related]
27. Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis.
Dassieu L; Kaboré JL; Choinière M; Arruda N; Roy É
Int J Drug Policy; 2019 Sep; 71():150-156. PubMed ID: 30975594
[TBL] [Abstract][Full Text] [Related]
28. Understanding the Impacts of Novel Coronavirus Outbreaks on People Who Use Drugs: A Systematic Review to Inform Practice and Drug Policy Responses to COVID-19.
Munro A; Booth H; Gray NM; Love J; Mohan ARM; Tang J; MacGillivray S
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444219
[TBL] [Abstract][Full Text] [Related]
29. A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island.
Collins AB; Edwards S; McNeil R; Goldman J; Hallowell BD; Scagos RP; Marshall BDL
Int J Drug Policy; 2022 May; 103():103626. PubMed ID: 35228056
[TBL] [Abstract][Full Text] [Related]
30. Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply.
Bonn M; Palayew A; Bartlett S; Brothers TD; Touesnard N; Tyndall M
J Stud Alcohol Drugs; 2020 Sep; 81(5):556-560. PubMed ID: 33028465
[TBL] [Abstract][Full Text] [Related]
31. Harm Reduction and Adaptations Among PWUD in Rural Oregon During COVID-19.
Seaman A; Leichtling G; Stack E; Gray M; Pope J; Larsen JE; Leahy JM; Gelberg L; Korthuis PT
AIDS Behav; 2021 May; 25(5):1331-1339. PubMed ID: 33471243
[TBL] [Abstract][Full Text] [Related]
32. "We just don't have the space for it": Geographies of survival and spatial triage in overdose prevention sites.
Olding M; Boyd J; Kerr T; McNeil R
Health Place; 2023 Sep; 83():103067. PubMed ID: 37352615
[TBL] [Abstract][Full Text] [Related]
33. "I'm not going to lay back and watch somebody die": A qualitative study of how people who use drugs' naloxone experiences are shaped by rural risk environment and naloxone distribution/overdose education intervention.
Kesich Z; Ibragimov U; Komro K; Lane K; Livingston M; Young A; Cooper H
Res Sq; 2023 Sep; ():. PubMed ID: 37720025
[TBL] [Abstract][Full Text] [Related]
34. COVID-19 and people who use drugs: Impact of the pandemic on general anxiety and depressive disorders among adults in Belgium.
Van Baelen L; Gremeaux L; Antoine J; Bruggeman H; Gisle L; Plettinckx E; De Ridder K
J Affect Disord; 2021 Dec; 295():946-953. PubMed ID: 34706467
[TBL] [Abstract][Full Text] [Related]
35. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
Shin SS; LaForge K; Stack E; Pope J; Leichtling G; Larsen JE; Leahy JM; Seaman A; Hoover D; Chisholm L; Blazes C; Baker R; Byers M; Branson K; Korthuis PT
Harm Reduct J; 2022 Jul; 19(1):76. PubMed ID: 35818072
[TBL] [Abstract][Full Text] [Related]
36. Exploring the Public Health Impacts of Private Security Guards on People Who Use Drugs: a Qualitative Study.
Markwick N; McNeil R; Small W; Kerr T
J Urban Health; 2015 Dec; 92(6):1117-30. PubMed ID: 26453195
[TBL] [Abstract][Full Text] [Related]
37. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
Davitadze A; Meylakhs P; Lakhov A; King EJ
Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
[TBL] [Abstract][Full Text] [Related]
38. Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada.
Pilarinos A; Barker B; Nosova E; Milloy MJ; Hayashi K; Wood E; Kerr T; DeBeck K
Addiction; 2020 Jan; 115(1):97-106. PubMed ID: 31379008
[TBL] [Abstract][Full Text] [Related]
39. A rapid review of the impacts of "Big Events " on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19.
Zolopa C; Hoj S; Bruneau J; Meeson JS; Minoyan N; Raynault MF; Makarenko I; Larney S
Int J Drug Policy; 2021 Jun; 92():103127. PubMed ID: 33549464
[TBL] [Abstract][Full Text] [Related]
40. Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site.
Kolla G; Tarannum CN; Fajber K; Worku F; Norris K; Long C; Fagundes R; Rucchetto A; Hannan E; Kikot R; Klaiman M; Firestone M; Bayoumi A; Laurence G; Hayman K
Harm Reduct J; 2024 Jan; 21(1):17. PubMed ID: 38243267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
